نتایج جستجو برای: stem cell transplant

تعداد نتایج: 1850382  

Journal: :Haematologica 2010
Dominique Farge Myriam Labopin Alan Tyndall Athanasios Fassas Gian Luigi Mancardi Jaap Van Laar Jian Ouyang Tomas Kozak John Moore Ina Kötter Virginie Chesnel Alberto Marmont Alois Gratwohl Riccardo Saccardi

BACKGROUND Autologous hematopoietic stem cell transplantation has been used since 1996 for the treatment of severe autoimmune diseases refractory to approved therapies. We evaluated the long-term outcomes of these transplants and aimed to identify potential prognostic factors. DESIGN AND METHODS In this observational study we analyzed all first autologous hematopoietic stem cell transplants f...

Journal: :iranian journal of basic medical sciences 0
nahid ataie nejad department of reproductive biology, faculty of medicine, tehran university of medical sciences, tehran, iran fardin amidi department of anatomical sciences, faculty of medicine, tehran university of medical sciences, tehran, iran marziyeh agha hoseini ivf center, shariati hospital, tehran university of medical sciences, tehran, iran karim nayer nia institute for molecular medicine and cell therapy, düsseldorf, germany and geneocell, advanced molecular & cellular technologies, tehran, iran mehryar habibi blood transfusion research center, high institute for research and education in transfusion medicine, tehran, iran abdol mohammad kajbafzadeh pediatric urology research center, children hospital medical center, tehran university of medical sciences, tehran, iran

objective(s):mesenchymal stem cells (mscs) derived from wharton’s jelly (wj-mscs) are now much more appealing for cell-based infertility therapy. hence, wj-mscs differentiation toward germ layer cells for cell therapy purposes is currently under intensive study. materials and methods: mscs were isolated from human wharton’s jelly and treated with bmp4, retinoic acid (ra) or co-cultured on human...

Journal: :Blood 1997
S K Nilsson M S Dooner C Y Tiarks H U Weier P J Quesenberry

Increasingly, allogeneic and even more often autologous bone marrow transplants are being done to correct a wide variety of diseases. In addition, autologous marrow transplants potentially provide an opportune means of delivering genes in transfected, engrafting stem cells. However, despite its widespread clinical use and promising gene therapy applications, relatively little is known about the...

Journal: :Future Oncology 2021

Mantle cell lymphoma is an aggressive B-cell malignancy. Current frontline chemoimmunotherapies produce high response rates but relapse inevitable. Furthermore, the elderly and those with comorbidities are precluded from standard regimens stem transplant, leaving them limited options. Targeted therapies, including Bruton tyrosine kinase inhibitors, effective treatment strategy in mantle lymphom...

2011
Salem Alshemmari Reem Ameen Javid Gaziev

Haploidentical hematopoietic stem-cell transplantation is an alternative transplant strategy for patients without an HLA-matched donor. Still, only half of patients who might benefit from transplantation are able to find an HLA-matched related or unrelated donor. Haploidentical donor is readily available for many patients in need of immediate stem-cell transplantation. Historical experience wit...

Journal: :Biology of Blood and Marrow Transplantation 2016

Journal: :Blood 1991
P J van Dijken J Wimperis J M Crawford J L Ferrara

We have examined the effect of graft-versus-host disease (GVHD) on the reconstitution of donor hematopoiesis in a murine bone marrow transplant (BMT) model of GVHD to minor histocompatibility antigens. GVHD had no effect on peripheral blood counts, which normalized by 1 month after BMT, and did not affect numbers of hematopoietic progenitors in the BM, which remained decreased in all transplant...

Journal: :Seminars in Oncology Nursing 2009

2004
Kanchan Rao Persis J Amrolia Alison Jones Catherine M Cale Paru Naik Doug King Graham E Davies H. Bobby Gaspar Paul A Veys

The optimal approach to stem cell transplantation in children with immunodeficiency who lack a matched family donor is controversial. Unrelated donor stem cell transplant gives equivalent outcome to mismatched family donor stem cell transplant in Severe combined immunodeficiency whereas unrelated donors may be preferable in nonSevere combined immunodeficiency children. However, unrelated donor ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید